ID

39645

Beschreibung

A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01567540

Link

https://clinicaltrials.gov/show/NCT01567540

Stichworte

Versionen (1)
  1. 07.02.20 07.02.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

7. Februar 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatitis C NCT01567540

Englisch

Eligibility Hepatitis C NCT01567540

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
age between 18 and 70 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
for women, effective contraception during the trial and a negative pregnancy test (urine) before enrollment
Beschreibung

Gender Contraceptive methods | Gender Urine pregnancy test negative

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0430057
patients naïve to prior hepatitis c treatment
Beschreibung

Therapy naive Hepatitis C

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0919936
UMLS CUI [1,2]
C0019196
confirmed hcv infection, based on the presence of hcv antibodies and plasma viremia allowing a measure of the circulating viral load
Beschreibung

Hepatitis C | Hepatitis C Antibodies Present | Plasma Viremia | Viral load measurement allowing

Datentyp

boolean

Alias
UMLS CUI [1]
C0019196
UMLS CUI [2,1]
C0166049
UMLS CUI [2,2]
C0150312
UMLS CUI [3,1]
C0032105
UMLS CUI [3,2]
C0042749
UMLS CUI [4,1]
C1261478
UMLS CUI [4,2]
C0683607
infection with hcv genotype 1 or 4
Beschreibung

Hepatitis C Genotype

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019196
UMLS CUI [1,2]
C1533728
intent of treatment alfa2 pegylated ifn-/ ribavirin
Beschreibung

Treatment intent PEGINTERFERON/RIBAVIRIN

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1292734
UMLS CUI [1,2]
C1875630
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
hbv infection
Beschreibung

Hepatitis B

Datentyp

boolean

Alias
UMLS CUI [1]
C0019163
hiv infection
Beschreibung

HIV Infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0019693
severe anemia (hb <7-8 g / dl)
Beschreibung

Anemia, severe | Hemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0238644
UMLS CUI [2]
C0518015
renal failure (creatinine clearance <60 ml / min)
Beschreibung

Kidney Failure | Creatinine clearance measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0035078
UMLS CUI [2]
C0373595
taking digoxin within 6 months of starting treatment.
Beschreibung

Digoxin

Datentyp

boolean

Alias
UMLS CUI [1]
C0012265
taking immunosuppressants within 6 months of starting treatment
Beschreibung

Immunosuppressive Agents

Datentyp

boolean

Alias
UMLS CUI [1]
C0021081
history of serious hypersensitivity reaction (such as anaphylactic shock or angioedema) to sitagliptin
Beschreibung

Allergic Reaction Serious Sitagliptin | Anaphylaxis | Angioedema

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C1565750
UMLS CUI [2]
C0002792
UMLS CUI [3]
C0002994
patients with type i and ii diabetes
Beschreibung

Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0011860
pregnancy or absence of effective contraception
Beschreibung

Pregnancy | Contraceptive methods Absent

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C0332197
a person deprived of liberty by judicial or administrative decision
Beschreibung

Person Deprivation Freedom

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027361
UMLS CUI [1,2]
C0871712
UMLS CUI [1,3]
C0016694
living conditions-suggesting an inability to track all scheduled visits by the protocol
Beschreibung

Compliance behavior Clinical Trial Visits Unable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0008976
UMLS CUI [1,3]
C0008952
UMLS CUI [1,4]
C1299582
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hepatitis C NCT01567540

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age between 18 and 70 years
boolean
C0001779 (UMLS CUI [1])
Gender Contraceptive methods | Gender Urine pregnancy test negative
Item
for women, effective contraception during the trial and a negative pregnancy test (urine) before enrollment
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2,1])
C0430057 (UMLS CUI [2,2])
Therapy naive Hepatitis C
Item
patients naïve to prior hepatitis c treatment
boolean
C0919936 (UMLS CUI [1,1])
C0019196 (UMLS CUI [1,2])
Hepatitis C | Hepatitis C Antibodies Present | Plasma Viremia | Viral load measurement allowing
Item
confirmed hcv infection, based on the presence of hcv antibodies and plasma viremia allowing a measure of the circulating viral load
boolean
C0019196 (UMLS CUI [1])
C0166049 (UMLS CUI [2,1])
C0150312 (UMLS CUI [2,2])
C0032105 (UMLS CUI [3,1])
C0042749 (UMLS CUI [3,2])
C1261478 (UMLS CUI [4,1])
C0683607 (UMLS CUI [4,2])
Hepatitis C Genotype
Item
infection with hcv genotype 1 or 4
boolean
C0019196 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
Treatment intent PEGINTERFERON/RIBAVIRIN
Item
intent of treatment alfa2 pegylated ifn-/ ribavirin
boolean
C1292734 (UMLS CUI [1,1])
C1875630 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Hepatitis B
Item
hbv infection
boolean
C0019163 (UMLS CUI [1])
HIV Infection
Item
hiv infection
boolean
C0019693 (UMLS CUI [1])
Anemia, severe | Hemoglobin measurement
Item
severe anemia (hb <7-8 g / dl)
boolean
C0238644 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
Kidney Failure | Creatinine clearance measurement
Item
renal failure (creatinine clearance <60 ml / min)
boolean
C0035078 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Digoxin
Item
taking digoxin within 6 months of starting treatment.
boolean
C0012265 (UMLS CUI [1])
Immunosuppressive Agents
Item
taking immunosuppressants within 6 months of starting treatment
boolean
C0021081 (UMLS CUI [1])
Allergic Reaction Serious Sitagliptin | Anaphylaxis | Angioedema
Item
history of serious hypersensitivity reaction (such as anaphylactic shock or angioedema) to sitagliptin
boolean
C1527304 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1565750 (UMLS CUI [1,3])
C0002792 (UMLS CUI [2])
C0002994 (UMLS CUI [3])
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent
Item
patients with type i and ii diabetes
boolean
C0011854 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Pregnancy | Contraceptive methods Absent
Item
pregnancy or absence of effective contraception
boolean
C0032961 (UMLS CUI [1])
C0700589 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Person Deprivation Freedom
Item
a person deprived of liberty by judicial or administrative decision
boolean
C0027361 (UMLS CUI [1,1])
C0871712 (UMLS CUI [1,2])
C0016694 (UMLS CUI [1,3])
Compliance behavior Clinical Trial Visits Unable
Item
living conditions-suggesting an inability to track all scheduled visits by the protocol
boolean
C1321605 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C0008952 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video